Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy
Authors
Keywords
-
Journal
OncoImmunology
Volume 7, Issue 6, Pages e1433982
Publisher
Informa UK Limited
Online
2018-02-01
DOI
10.1080/2162402x.2018.1433982
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of interleukin-2, all-trans retinoic acid, and natural killer cells: surveillance mechanisms in anti-GD2 antibody therapy in neuroblastoma
- (2018) Rosa Nguyen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Sipuleucel-T for the treatment of prostate cancer: novel insights and future directions
- (2018) Catherine E Handy et al. Future Oncology
- The fibrotic tumor stroma
- (2018) Mitsuo Yamauchi et al. JOURNAL OF CLINICAL INVESTIGATION
- Cancer Associated Fibroblasts: The Architects of Stroma Remodeling
- (2018) Alice Santi et al. PROTEOMICS
- Cross Talk between Radiation and Immunotherapy: The Twain Shall Meet
- (2018) Swaminathan P. Iyer et al. RADIATION RESEARCH
- New Trends in Anti-Cancer Therapy: Combining Conventional Chemotherapeutics with Novel Immunomodulators
- (2018) Amy L. Wilson et al. CURRENT MEDICINAL CHEMISTRY
- Single vs. combination immunotherapeutic strategies for glioma
- (2017) Mayuri Chandran et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- High-dose interleukin-2 (IL-2) for the treatment of melanoma: safety considerations and future directions
- (2017) Stephen Marabondo et al. Expert Opinion On Drug Safety
- Clinical development of mTor inhibitors for renal cancer
- (2017) Michele Ghidini et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Anti-GD2 immunotherapy for neuroblastoma
- (2017) Sameer Sait et al. Expert Review of Anticancer Therapy
- cGAS Micro-Manages Genotoxic Stress
- (2017) Mona Motwani et al. IMMUNITY
- IL-1 and IL-1 regulatory pathways in cancer progression and therapy
- (2017) Alberto Mantovani et al. IMMUNOLOGICAL REVIEWS
- Immune recognition of irradiated cancer cells
- (2017) Erik Wennerberg et al. IMMUNOLOGICAL REVIEWS
- The family of the interleukin-1 receptors
- (2017) Diana Boraschi et al. IMMUNOLOGICAL REVIEWS
- Tuning inflammation and immunity by the negative regulators IL-1R2 and IL-1R8
- (2017) Martina Molgora et al. IMMUNOLOGICAL REVIEWS
- The potential and promise of IL-15 in immuno-oncogenic therapies
- (2017) Tanya O. Robinson et al. IMMUNOLOGY LETTERS
- cGAS/STING Pathway in Cancer: Jekyll and Hyde Story of Cancer Immune Response
- (2017) Debojit Bose INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation
- (2017) Franco Trevisani et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- CD56bright NK cells exhibit potent antitumor responses following IL-15 priming
- (2017) Julia A. Wagner, Maximillian Rosario, Rizwan Romee, Melissa M. Berrien-Elliott, Stephanie E. Schneider, Jeffrey W. Leong, Ryan P. Sullivan, Brea A. Jewell, Michelle Becker-Hapak, Timothy Schappe, Sara Abdel-Latif, Aaron R. Ireland, Devika Jaishankar, Justin A. King, Ravi Vij, Dennis Clement, Jodie Goodridge, Karl-Johan Malmberg, Hing C. Wong, Todd A. Fehniger JOURNAL OF CLINICAL INVESTIGATION
- IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
- (2017) Mark Ayers et al. JOURNAL OF CLINICAL INVESTIGATION
- Patterns of relapse and second malignancy after adjuvant external beam radiation therapy for stage I-II seminoma.
- (2017) Erik Steven Anderson et al. JOURNAL OF CLINICAL ONCOLOGY
- Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial
- (2017) Christopher R Heery et al. LANCET ONCOLOGY
- Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial
- (2017) Georgina V Long et al. LANCET ONCOLOGY
- Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial
- (2017) James L Gulley et al. LANCET ONCOLOGY
- Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity
- (2017) E Liu et al. LEUKEMIA
- DNA Damage in Stem Cells
- (2017) Ilio Vitale et al. MOLECULAR CELL
- IL-1R8 is a checkpoint in NK cells regulating anti-tumour and anti-viral activity
- (2017) Martina Molgora et al. NATURE
- cGAS surveillance of micronuclei links genome instability to innate immunity
- (2017) Karen J. Mackenzie et al. NATURE
- Mitotic progression following DNA damage enables pattern recognition within micronuclei
- (2017) Shane M. Harding et al. NATURE
- Cytoplasmic chromatin triggers inflammation in senescence and cancer
- (2017) Zhixun Dou et al. NATURE
- Immunotherapy: Hiding in plain sight: immune escape in the era of targeted T-cell-based immunotherapies
- (2017) Anthony F. Daniyan et al. Nature Reviews Clinical Oncology
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- Lessons from immuno-oncology: a new era for cancer nanomedicine?
- (2017) Wen Jiang et al. NATURE REVIEWS DRUG DISCOVERY
- Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles
- (2017) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- Tumor Vaccines for Malignant Gliomas
- (2017) Visish M. Srinivasan et al. Neurotherapeutics
- Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
- (2017) Scott J. Antonia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma
- (2017) James R. Perry et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase II Trial of Sorafenib in Combination with Capecitabine in Patients with Hepatocellular Carcinoma: INST 08‐20
- (2017) Yehuda Patt et al. ONCOLOGIST
- cGAS Conducts Micronuclei DNA Surveillance
- (2017) Carina C. de Oliveira Mann et al. TRENDS IN CELL BIOLOGY
- TREX1 Cuts Down on Cancer Immunogenicity
- (2017) Takahiro Yamazaki et al. TRENDS IN CELL BIOLOGY
- IL-21-mediated reversal of NK cell exhaustion facilitates anti-tumour immunity in MHC class I-deficient tumours
- (2017) Hyungseok Seo et al. Nature Communications
- DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
- (2017) Claire Vanpouille-Box et al. Nature Communications
- Targeting of CD122 enhances antitumor immunity by altering the tumor immune environment
- (2017) Daniel O. Villarreal et al. Oncotarget
- High IL-1R8 expression in breast tumors promotes tumor growth and contributes to impaired antitumor immunity
- (2017) Luis Felipe Campesato et al. Oncotarget
- New interleukin-15 superagonist (IL-15SA) significantly enhances graft-versus-tumor activity
- (2017) Cavan P. Bailey et al. Oncotarget
- Endothelial-derived interleukin-6 induces cancer stem cell motility by generating a chemotactic gradient towards blood vessels
- (2017) Hong Sun Kim et al. Oncotarget
- Positive Regulation of Interleukin-1β Bioactivity by Physiological ROS-Mediated Cysteine S-Glutathionylation
- (2017) Xue Zhang et al. Cell Reports
- Augmentation of Antitumor Immunity by Human and Mouse CAR T Cells Secreting IL-18
- (2017) Biliang Hu et al. Cell Reports
- TargetingO-Acetyl-GD2 Ganglioside for Cancer Immunotherapy
- (2017) Julien Fleurence et al. Journal of Immunology Research
- Total Skin Electron Beam Therapy as Part of Multimodal Treatment Strategies for Primary Cutaneous T-Cell Lymphoma
- (2017) Khaled Elsayad et al. Oncology Research and Treatment
- Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model
- (2017) Paola Bocca et al. OncoImmunology
- Response to first line chemotherapy regimen is associated with efficacy of nivolumab in non-small-cell lung cancer
- (2017) Courèche-Guillaume Kaderbhai et al. OncoImmunology
- The influence of stromal cells and tumor-microenvironment-derived cytokines and chemokines on CD3+CD8+ tumor infiltrating lymphocyte subpopulations
- (2017) Stefan Koeck et al. OncoImmunology
- Cyclophosphamide treatment regulates the balance of functional/exhausted tumor-specific CD8+ T cells
- (2017) Aurélie Hanoteau et al. OncoImmunology
- Ionizing radiation sensitizes tumors to PD-L1 immune checkpoint blockade in orthotopic murine head and neck squamous cell carcinoma
- (2017) Ayman Oweida et al. OncoImmunology
- Factors released by the tumor far microenvironment are decisive for pancreatic adenocarcinoma development and progression
- (2017) Juan L. Iovanna et al. OncoImmunology
- Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications
- (2017) Mariona Cabo et al. OncoImmunology
- Interleukin-21 combined with PD-1 or CTLA-4 blockade enhances antitumor immunity in mouse tumor models
- (2017) Katherine E. Lewis et al. OncoImmunology
- PD-L1 inhibitors in the pipeline: Promise and progress
- (2017) Vito Vanella et al. OncoImmunology
- Trial Watch: Adoptively transferred cells for anticancer immunotherapy
- (2017) Carole Fournier et al. OncoImmunology
- Immune evasion mechanisms and immune checkpoint inhibition in advanced merkel cell carcinoma
- (2017) Dirk Schadendorf et al. OncoImmunology
- mSA2 affinity-enhanced biotin-binding CAR T cells for universal tumor targeting
- (2017) Jason J. Lohmueller et al. OncoImmunology
- Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer
- (2017) Dhifaf Sarhan et al. OncoImmunology
- Immunological efficacy of glypican-3 peptide vaccine in patients with advanced hepatocellular carcinoma
- (2017) Nobuhiro Tsuchiya et al. OncoImmunology
- Blinatumomab bridges the gap between leukemia and immunity
- (2017) Takahiro Yamazaki et al. OncoImmunology
- Complete regression of cutaneous metastases with systemic immune response in a patient with triple negative breast cancer receiving p53MVA vaccine with pembrolizumab
- (2017) Yuan Yuan et al. OncoImmunology
- Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors
- (2017) Nobuhiro Tsuchiya et al. OncoImmunology
- CARs on a highway with roadblocks
- (2017) Lorenzo Galluzzi et al. OncoImmunology
- Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma
- (2017) Valérie Dutoit et al. OncoImmunology
- Expression profiles of immune-related genes are associated with neoadjuvant ipilimumab clinical benefit
- (2017) Ahmad A. Tarhini et al. OncoImmunology
- Trial watch: DNA-based vaccines for oncological indications
- (2017) Stefano Pierini et al. OncoImmunology
- Bispecific antibody does not induce T-cell death mediated by chimeric antigen receptor against disialoganglioside GD2
- (2017) Sayed Shahabuddin Hoseini et al. OncoImmunology
- Trial watch: Dendritic cell-based anticancer immunotherapy
- (2017) Abhishek D. Garg et al. OncoImmunology
- Toll-like receptor 2 ligand and interferon-γ suppress anti-tumor T cell responses by enhancing the immunosuppressive activity of monocytic myeloid-derived suppressor cells
- (2017) Hiroaki Shime et al. OncoImmunology
- Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics
- (2017) Abhishek D. Garg et al. OncoImmunology
- Trial watch: Immune checkpoint blockers for cancer therapy
- (2017) Claire Vanpouille-Box et al. OncoImmunology
- IL-21 promotes the development of a CD73-positive Vγ9Vδ2 T cell regulatory population
- (2017) Clément Barjon et al. OncoImmunology
- Correlation between previous treatment with BRAF inhibitors and clinical response to pembrolizumab in patients with advanced melanoma
- (2017) Ester Simeone et al. OncoImmunology
- Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation
- (2017) Rūta Veinalde et al. OncoImmunology
- Modeling the receptor pharmacology, pharmacokinetics, and pharmacodynamics of NKTR-214, a kinetically-controlled interleukin-2 (IL2) receptor agonist for cancer immunotherapy
- (2017) Deborah Charych et al. PLoS One
- Immunotherapeutic Interleukin-6 or Interleukin-6 Receptor Blockade in Cancer: Challenges and Opportunities
- (2017) Nirmala Chandralega Kampan et al. CURRENT MEDICINAL CHEMISTRY
- Systematic review of the use of granulocyte–macrophage colony-stimulating factor in patients with advanced melanoma
- (2016) Christoph Hoeller et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- IL15 Agonists Overcome the Immunosuppressive Effects of MEK Inhibitors
- (2016) M. J. Allegrezza et al. CANCER RESEARCH
- Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
- (2016) Jianjun Gao et al. CELL
- Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
- (2016) Joseph L. Benci et al. CELL
- Metabolic Control of Longevity
- (2016) Carlos López-Otín et al. CELL
- NKTR-214, an Engineered Cytokine with Biased IL2 Receptor Binding, Increased Tumor Exposure, and Marked Efficacy in Mouse Tumor Models
- (2016) D. H. Charych et al. CLINICAL CANCER RESEARCH
- A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma
- (2016) R. Rampling et al. CLINICAL CANCER RESEARCH
- Early Tumour Shrinkage: A Tool for the Detection of Early Clinical Activity in Metastatic Renal Cell Carcinoma
- (2016) Viktor Grünwald et al. EUROPEAN UROLOGY
- Immunological effects of chemotherapy and radiotherapy against brain tumors
- (2016) Tobias Weiss et al. Expert Review of Anticancer Therapy
- Caspases Connect Cell-Death Signaling to Organismal Homeostasis
- (2016) Lorenzo Galluzzi et al. IMMUNITY
- A Novel Fusion of ALT-803 (Interleukin (IL)-15 Superagonist) with an Antibody Demonstrates Antigen-specific Antitumor Responses
- (2016) Bai Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The host STING pathway at the interface of cancer and immunity
- (2016) Leticia Corrales et al. JOURNAL OF CLINICAL INVESTIGATION
- Randomized phase II study of the safety, efficacy, and immune response of GVAX pancreas (with cyclophosphamide) and CRS-207 with or without nivolumab in patients with previously treated metastatic pancreatic adenocarcinoma (STELLAR).
- (2016) Dung T. Le et al. JOURNAL OF CLINICAL ONCOLOGY
- Combined IL-21–primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient
- (2016) Aude G. Chapuis et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
- (2016) Howard L Kaufman et al. LANCET ONCOLOGY
- Regulation and function of the cGAS–STING pathway of cytosolic DNA sensing
- (2016) Qi Chen et al. NATURE IMMUNOLOGY
- The future of cancer treatment: immunomodulation, CARs and combination immunotherapy
- (2016) Danny N. Khalil et al. Nature Reviews Clinical Oncology
- Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy
- (2016) Lorenzo Galluzzi et al. Nature Reviews Clinical Oncology
- Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets
- (2016) Yufang Shi et al. NATURE REVIEWS DRUG DISCOVERY
- Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells
- (2016) Lenka V. Hurton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanism and Regulation of NLRP3 Inflammasome Activation
- (2016) Yuan He et al. TRENDS IN BIOCHEMICAL SCIENCES
- Selective targeting of IL-2 to NKG2D bearing cells for improved immunotherapy
- (2016) Reza Ghasemi et al. Nature Communications
- Induction of IL-25 secretion from tumour-associated fibroblasts suppresses mammary tumour metastasis
- (2016) Shu-Yi Yin et al. Nature Communications
- Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma
- (2016) A. Mishra et al. Cancer Discovery
- GM-CSF Mediates Mesenchymal-Epithelial Cross-talk in Pancreatic Cancer
- (2016) M. Waghray et al. Cancer Discovery
- Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence
- (2016) Elizabeth A. Mittendorf et al. Oncotarget
- Trial Watch: Immunotherapy plus radiation therapy for oncological indications
- (2016) Erika Vacchelli et al. OncoImmunology
- Fine-tuning the CAR spacer improves T-cell potency
- (2016) Norihiro Watanabe et al. OncoImmunology
- Combating rituximab resistance by inducing ceramide/lysosome-involved cell death through initiation of CD20-TNFR1 co-localization
- (2016) Fan Zhang et al. OncoImmunology
- Antitumor vaccination of prostate cancer patients elicits PD-1/PD-L1 regulated antigen-specific immune responses
- (2016) Brian T. Rekoske et al. OncoImmunology
- Anti-GD2 mAb and Vorinostat synergize in the treatment of neuroblastoma
- (2016) Michiel Kroesen et al. OncoImmunology
- Anti-CD137 enhances anti-CD20 therapy of systemic B-cell lymphoma with altered immune homeostasis but negligible toxicity
- (2016) Fernando Souza-Fonseca-Guimaraes et al. OncoImmunology
- mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma
- (2016) Troels Holz Borch et al. OncoImmunology
- IL-15 enhances the antitumor effect of human antigen-specific CD8+ T cells by cellular senescence delay
- (2016) Jinsheng Weng et al. OncoImmunology
- Regulation of myeloid cells by activated T cells determines the efficacy of PD-1 blockade
- (2016) Nina Eissler et al. OncoImmunology
- Trial Watch—Small molecules targeting the immunological tumor microenvironment for cancer therapy
- (2016) Aitziber Buqué et al. OncoImmunology
- Adjuvants for peptide-based cancer vaccines
- (2016) Hiep Khong et al. Journal for ImmunoTherapy of Cancer
- Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?
- (2016) Valérie Dutoit et al. Frontiers in Oncology
- A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer
- (2015) E. M. Dijkgraaf et al. ANNALS OF ONCOLOGY
- A targeted IL-15 fusion protein with potent anti-tumor activity
- (2015) Siqi Chen et al. CANCER BIOLOGY & THERAPY
- Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
- (2015) Lorenzo Galluzzi et al. CANCER CELL
- The role of IL-21 in immunity and cancer
- (2015) Matthew R. Davis et al. CANCER LETTERS
- Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
- (2015) Padmanee Sharma et al. CELL
- Total Skin Electron Beam for Primary Cutaneous T-cell Lymphoma
- (2015) Khaled Elsayad et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Randomized, Placebo-Controlled, Phase III Trial of Yeast-Derived Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With No Evidence of Disease After Complete Surgical Resection of Locally Advanced and/or Stage IV Melanoma: A Trial of the Eastern Cooperative Oncology Group–American College of Radiology Imaging Network Cancer Research Group (E4697)
- (2015) David H. Lawson et al. JOURNAL OF CLINICAL ONCOLOGY
- Two courses of four weekly infusions of rituximab with or without interferon-α2a: final results from a randomized phase III study in symptomatic indolent B-cell lymphomas
- (2015) Eva Kimby et al. LEUKEMIA & LYMPHOMA
- Natural and therapy-induced immunosurveillance in breast cancer
- (2015) Guido Kroemer et al. NATURE MEDICINE
- Anti-PD-1 therapies—a new first-line option in advanced melanoma
- (2015) Ryan J. Sullivan et al. Nature Reviews Clinical Oncology
- Combination cancer immunotherapies tailored to the tumour microenvironment
- (2015) Mark J. Smyth et al. Nature Reviews Clinical Oncology
- Big opportunities for small molecules in immuno-oncology
- (2015) Jerry L. Adams et al. NATURE REVIEWS DRUG DISCOVERY
- Navigating the bone marrow niche: translational insights and cancer-driven dysfunction
- (2015) Michaela R. Reagan et al. Nature Reviews Rheumatology
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- First clinical results of a personalized immunotherapeutic vaccine against recurrent, incompletely resected, treatment-resistant glioblastoma multiforme (GBM) tumors, based on combined allo- and auto-immune tumor reactivity
- (2015) Virgil E.J.C. Schijns et al. VACCINE
- Cooperative therapeutic anti-tumor effect of IL-15 agonist ALT-803 and co-targeting soluble NKG2D ligand sMIC
- (2015) Fahmin Basher et al. Oncotarget
- Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death
- (2015) Abhishek D. Garg et al. Frontiers in Immunology
- First oncolytic virus approved for melanoma immunotherapy
- (2015) Jonathan Pol et al. OncoImmunology
- Trial Watch—Immunostimulation with cytokines in cancer therapy
- (2015) Erika Vacchelli et al. OncoImmunology
- Interleukin 6 Receptor Is an Independent Prognostic Factor and a Potential Therapeutic Target of Ovarian Cancer
- (2015) Aki Isobe et al. PLoS One
- Clinical outcomes of a novel combination of lenalidomide and rituximab followed by stem cell transplantation for relapsed/refractory aggressive B-cell non-hodgkin lymphoma
- (2015) Qingqing Cai et al. Oncotarget
- Classification of current anticancer immunotherapies
- (2015) Lorenzo Galluzzi et al. Oncotarget
- SnapShot: Cancer Vaccines
- (2014) Karolina Palucka et al. CELL
- Ipilimumab Plus Sargramostim vs Ipilimumab Alone for Treatment of Metastatic Melanoma
- (2014) F. Stephen Hodi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Smart therapeutic strategies in immuno-oncology
- (2014) Alexander M. M. Eggermont et al. Nature Reviews Clinical Oncology
- Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
- (2014) Fotios Loupakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trial Watch
- (2014) Fernando Aranda et al. OncoImmunology
- Trial watch: IDO inhibitors in cancer therapy
- (2014) Erika Vacchelli et al. OncoImmunology
- Current status of granulocyte–macrophage colony-stimulating factor in the immunotherapy of melanoma
- (2014) Howard L Kaufman et al. Journal for ImmunoTherapy of Cancer
- A multinational phase II trial of bevacizumab with low-dose interferon- 2a as first-line treatment of metastatic renal cell carcinoma: BEVLiN
- (2013) B. Melichar et al. ANNALS OF ONCOLOGY
- Pegfilgrastim prophylaxis is associated with a lower risk of hospitalization of cancer patients than filgrastim prophylaxis: a retrospective United States claims analysis of granulocyte colony-stimulating factors (G-CSF)
- (2013) Arash Naeim et al. BMC CANCER
- Efficacy and Mechanism-of-Action of a Novel Superagonist Interleukin-15: Interleukin-15 Receptor Su/Fc Fusion Complex in Syngeneic Murine Models of Multiple Myeloma
- (2013) W. Xu et al. CANCER RESEARCH
- A Randomized Phase II Trial of Multiepitope Vaccination with Melanoma Peptides for Cytotoxic T Cells and Helper T Cells for Patients with Metastatic Melanoma (E1602)
- (2013) C. L. Slingluff et al. CLINICAL CANCER RESEARCH
- Crosstalk between ER stress and immunogenic cell death
- (2013) Oliver Kepp et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Randomized Phase III Trial of Temsirolimus and Bevacizumab Versus Interferon Alfa and Bevacizumab in Metastatic Renal Cell Carcinoma: INTORACT Trial
- (2013) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
- Structural mechanism of cytosolic DNA sensing by cGAS
- (2013) Filiz Civril et al. NATURE
- Pivotal Roles of cGAS-cGAMP Signaling in Antiviral Defense and Immune Adjuvant Effects
- (2013) X.-D. Li et al. SCIENCE
- Trial Watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Trial watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose escalation of cytarabine
- (2012) T. Pabst et al. BLOOD
- Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy
- (2012) Valérie Dutoit et al. BRAIN
- Metronomic chemotherapy with low-dose cyclophosphamide plus gemcitabine can induce anti-tumor T cell immunity in vivo
- (2012) Miki Tongu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Regulatory T-cell Modulation Using Cyclophosphamide in Vaccine Approaches: A Current Perspective
- (2012) D. T. Le et al. CANCER RESEARCH
- Isolated limb perfusion of soft tissue sarcomas: A comprehensive review of literature
- (2012) Jojanneke M. Seinen et al. CANCER TREATMENT REVIEWS
- A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study)
- (2012) C. Sebban et al. EUROPEAN JOURNAL OF CANCER
- Cost-Utility Analysis of Primary Prophylaxis Versus Secondary Prophylaxis With Granulocyte Colony-Stimulating Factor in Elderly Patients With Diffuse Aggressive Lymphoma Receiving Curative-Intent Chemotherapy
- (2012) Kelvin K.W. Chan et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Results of the Randomized Phase III Trial EORTC 18991 of Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III Melanoma
- (2012) Alexander M.M. Eggermont et al. JOURNAL OF CLINICAL ONCOLOGY
- Hyperthermic isolated limb perfusion for extremity soft tissue sarcomas: Systematic review of clinical efficacy and quality assessment of reported trials
- (2012) N.H. Trabulsi et al. JOURNAL OF SURGICAL ONCOLOGY
- Inflammasomes in carcinogenesis and anticancer immune responses
- (2012) Laurence Zitvogel et al. NATURE IMMUNOLOGY
- Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
- (2012) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical and Safety Profile of High-Dose Interleukin-2 Treatment in Elderly Patients with Metastatic Melanoma and Renal Cell Carcinoma
- (2012) James M. Clark et al. ONCOLOGY
- An Optimized Method for Manufacturing a Clinical Scale Dendritic Cell-Based Vaccine for the Treatment of Glioblastoma
- (2012) Sara Nava et al. PLoS One
- Trial Watch: Monoclonal antibodies in cancer therapy
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Trial Watch
- (2012) Erika Vacchelli et al. OncoImmunology
- 20 Years Experience of TNF-Based Isolated Limb Perfusion for In-Transit Melanoma Metastases: TNF Dose Matters
- (2011) Jan P. Deroose et al. ANNALS OF SURGICAL ONCOLOGY
- Long-term outcome of isolated limb perfusion with tumour necrosis factor-α for patients with melanoma in-transit metastases
- (2011) J. P. Deroose et al. BRITISH JOURNAL OF SURGERY
- Adjuvants for Enhancing the Immunogenicity of Whole Tumor Cell Vaccines
- (2011) Cheryl Lai-Lai Chiang et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Long-Term Results of Tumor Necrosis Factor α– and Melphalan-Based Isolated Limb Perfusion in Locally Advanced Extremity Soft Tissue Sarcomas
- (2011) Jan P. Deroose et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Efficacy of Combination Immunotherapy With Interferon Alfa-2b and Tremelimumab in Patients With Stage IV Melanoma
- (2011) Ahmad A. Tarhini et al. JOURNAL OF CLINICAL ONCOLOGY
- Fludarabine plus alemtuzumab versus fludarabine alone in patients with previously treated chronic lymphocytic leukaemia: a randomised phase 3 trial
- (2011) Thomas Elter et al. LANCET ONCOLOGY
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overall survival in patients with metastatic renal cell carcinoma initially treated with bevacizumab plus interferon-α2a and subsequent therapy with tyrosine kinase inhibitors: a retrospective analysis of the phase III AVOREN trial
- (2010) Sergio Bracarda et al. BJU INTERNATIONAL
- Are neutralizing anti-GM-CSF autoantibodies present in all healthy persons?
- (2010) A. Meager et al. BLOOD
- IL-17 family member cytokines: Regulation and function in innate immunity
- (2010) Joseph M. Reynolds et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Phase III Trial of Bevacizumab Plus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma (AVOREN): Final Analysis of Overall Survival
- (2010) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- IL25 elicits a multipotent progenitor cell population that promotes TH2 cytokine responses
- (2010) Steven A. Saenz et al. NATURE
- Targeting Toll-like receptors: emerging therapeutics?
- (2010) Elizabeth J. Hennessy et al. NATURE REVIEWS DRUG DISCOVERY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- FDA Drug Approval Summary: Bevacizumab plus Interferon for Advanced Renal Cell Carcinoma
- (2010) J. Summers et al. ONCOLOGIST
- Immunomodulation of FOXP3+ Regulatory T Cells by the Aromatase Inhibitor Letrozole in Breast Cancer Patients
- (2009) D. Generali et al. CLINICAL CANCER RESEARCH
- Epigenetic Modifiers: Basic Understanding and Clinical Development
- (2009) R. L. Piekarz et al. CLINICAL CANCER RESEARCH
- Recombinant Human Granulocyte-macrophage Colony-stimulating Factor (GM-CSF, Sargramostim) Administered for 3 Years as Adjuvant Therapy of Stages II(T4), III, and IV Melanoma
- (2009) Lynn E. Spitler et al. JOURNAL OF IMMUNOTHERAPY
- NOD-Like Receptors: Role in Innate Immunity and Inflammatory Disease
- (2008) Grace Chen et al. Annual Review of Pathology-Mechanisms of Disease
- SnapShot: Cytokines I
- (2008) Cristina M. Tato et al. CELL
- SnapShot: Cytokines IV
- (2008) Cristina M. Tato et al. CELL
- Interactions between Bortezomib and Romidepsin and Belinostat in Chronic Lymphocytic Leukemia Cells
- (2008) Y. Dai et al. CLINICAL CANCER RESEARCH
- Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206
- (2008) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started